Full Text View
Tabular View
Study Results
Related Studies
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
This study has been completed.
Study NCT00895817   Information provided by Walter Reed Army Medical Center

First Received on May 6, 2009.   Last Updated on March 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eosinophilic Esophagitis
Additional conditions recognized in this trial
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Eosinophilia
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Hematologic Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Leukocyte Disorders
Interventions listed in this trial
Swallowed fluticasone
Esomeprazole
Additional drug interventions recognized in this trial
Fluticasone
Omeprazole
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Anti-Ulcer Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Walter Reed Army Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services